BioXcell代理欣博盛生物：InVivoPlus anti-mouse PD-L1 (B7-H1)

更新時間：2023-05-18 點擊次數：607次

BioXcell熱銷產品推薦--InVivoPlus anti-mouse PD-L1 (B7-H1)

產品描述：

BioXcell InVivoPlus anti-mouse PD-L1 10F.9G2單克隆抗體與小鼠PD-L1（也稱為B7-H1或CD274）反應。PD-L1是屬于Ig超家族的B7家族的I型跨膜蛋白，分子量為40kDa。PD-L1在T淋巴細胞、B淋巴細胞、NK細胞、樹突狀細胞以及IFNγ刺激的單核細胞、上皮細胞和內皮細胞上表達。PD-L1與CD4和CD8胸腺細胞以及活化的T和B淋巴細胞和骨髓細胞上的受體PD-1結合。PD-L1與PD-1的結合導致抑制TCR介導的T細胞增殖和細胞因子產生。PD-L1被認為在腫瘤免疫逃逸中起著重要作用。誘導的PD-L1表達在許多腫瘤中很常見，并導致腫瘤細胞對CD8 T細胞介導的裂解的抗性增加。在黑色素瘤的小鼠模型中，可以通過用阻斷PD-L1和PD-1之間相互作用的抗體進行治療，暫時抑制腫瘤生長。10F.9G2抗體已被證明可以阻斷PD-L1和PD-1之間以及PD-L1和B7-1之間的相互作用（CD80）。

BioXcell熱銷產品推薦--InVivoPlus anti-mouse PD-L1 (B7-H1)

產品詳情：

產品名稱	InVivoPlus anti-mouse PD-L1 (B7-H1)
產品貨號	BP0101
產品規格	5/25/50/100mg
反應種屬	Mouse
克隆號	10F.9G2
同種型	Rat IgG2b, κ
免疫原	Mouse CD274
實驗應用	in vivo PD-L1 blockade Immunofluorescence Immunohistochemistry (frozen) Flow cytometry Western blot
產品形式	PBS, pH 6.5,Contains no stabilizers or preservatives
純度	>95%, Determined by SDS-PAGE
聚合	<5%, Determined by SEC
無菌處理	0.2 µm filtration
純化方式	Protein G
RRID	AB_10949073
分子量	150 kDa
小鼠病原檢測	Ectromelia/Mousepox Virus: Negative Hantavirus: Negative K Virus: Negative Lactate Dehydrogenase-Elevating Virus: Negative Lymphocytic Choriomeningitis virus: Negative Mouse Adenovirus: Negative Mouse Cytomegalovirus: Negative Mouse Hepatitis Virus: Negative Mouse Minute Virus: Negative Mouse Norovirus: Negative Mouse Parvovirus: Negative Mouse Rotavirus: Negative Mycoplasma Pulmonis: Negative Pneumonia Virus of Mice: Negative Polyoma Virus: Negative Reovirus Screen: Negative Sendai Virus: Negative Theiler’s Murine Encephalomyelitis: Negative
保存條件	抗體原液保存在4°C，不能冷凍保存。
推薦同型對照	InVivoPlus rat IgG2b isotype control, anti-keyhole limpet hemocyanin（貨號BP0090）
推薦抗體稀釋液	InVivoPure pH 6.5 Dilution Buffer（貨號IP0065）

為什么選擇InVivoPlus抗體？

InVivoPlus級別的產品內毒素含量更低，經過多種實驗驗證，更適合用于體內實驗研究

BioXcell熱銷產品推薦--InVivoPlus anti-mouse PD-L1 (B7-H1)

該產品自上市已被多篇SCI文獻引用，品質有保證，以下是部分已發表的文獻引用：

應用

文章

體內PD-L1阻斷

(in vivo PD-L1 blockade)

1. Grasselly, C., et al. (2018). 'The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent' Front Immunol 9: 2100.

2. Stathopoulou, C., et al. (2018). 'PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells' Immunity 49(2): 247-263 e247.

3. Kim, J., et al. (2015). 'Memory programming in CD8(+) T-cell differentiation is intrinsic and is not determined by CD4 help' Nat Commun 6: 7994.

體內PD-L1阻斷，流式細胞術

(in vivo PD-L1 blockade, Flow Cytometry)

1. Aloulou, M., et al. (2016). 'Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells' Nat Commun 7: 10579.

2. Ngiow, S. F., et al. (2015). 'A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1' Cancer Res 75(18): 3800-3811.

3. Rutigliano, J. A., et al. (2014). 'Highly pathological influenza A virus infection is associated with augmented expression of PD-1 by functionally compromised virus-specific CD8+ T cells' J Virol 88(3): 1636-1651.

體內PD-L1阻斷，免疫熒光

(in vivo PD-L1 blockade, Immunofluorescence)

1.Willimsky, G., et al. (2013). 'Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance' J Clin Invest 123(3): 1032-1043.

免疫組織化學（冷凍切片），免疫熒光

(Immunohistochemistry (frozen), Immunofluorescence)

1.Riella, L. V., et al. (2011). 'Essential role of PDL1 expression on nonhematopoietic donor cells in acquired tolerance to vascularized cardiac allografts' Am J Transplant 11(4): 832-840.

BioXcell熱銷產品推薦--InVivoPlus anti-mouse PD-L1 (B7-H1)

更多產品詳情請聯系 BioXcell 中國授權代理——欣博盛生物

上一篇：白介素試劑盒——解密身體免疫調節的“指揮官”

下一篇：BioXcell熱銷產品--InVivoPlus rat IgG2a isotype control

返回列表>>